Status:
COMPLETED
Exercise and Acarbose in Type 2 Diabetes
Lead Sponsor:
Karolinska Institutet
Collaborating Sponsors:
The Swedish Research Council
Bayer
Conditions:
Diabetes Mellitus Type 2
Eligibility:
All Genders
45-60 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to investigate the impact of exercise training, Acarbose, and the combination of exercise and Acarbose on glycemic control, body composition, insulin sensitivity and other...
Eligibility Criteria
Inclusion
- Men and women, diagnosis of type 2 diabetes established since at least three months, treatment with diet or maximum one oral anti-diabetic drug, GHb \< 8.5 %, age 45 - 60 years, BMI 25 - 30 kg/m2, no participation in any regular exercise program.
- \-
Exclusion
- Unable to perform exercise, significant GI-disease, severe heart-disease, renal failure
- \-
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT01244971
Start Date
January 1 2004
Last Update
November 22 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Enheten för Metabol Kontroll, Endokrinkliniken, Karolinska University Hospital
Stockholm, Stockholm County, Sweden, 17176